Topiramate
Rx
Generic NameTopiramate
Therapeutic ClassAntiepileptic / Anticonvulsant
Common Dose25–200 mg/day (divided doses)
Max / 24h400 mg/day
PregnancyUse with caution (may cause fetal harm)
Indications ▼
Partial-onset seizures (monotherapy or adjunct)
Primary generalized tonic-clonic seizures
Lennox-Gastaut syndrome (adjunct therapy)
Migraine prophylaxis in adults
Mechanism & Pharmacokinetics ▼
Mechanism: Topiramate blocks voltage-dependent sodium channels, enhances GABA activity, antagonizes AMPA/kainate glutamate receptors, and inhibits carbonic anhydrase, reducing neuronal excitability.
Absorption: Rapid and nearly complete; bioavailability ~80%
Metabolism: Partially hepatic via CYP3A4 and CYP2C19; mainly excreted unchanged in urine
Half-life: ~21 hours (can vary with enzyme-inducing drugs)
Dosage & Administration ▼
Start low, titrate gradually to minimize side effects
Typical starting dose: 25 mg/day, increase weekly by 25–50 mg
Target dose: 100–200 mg/day for monotherapy; 200–400 mg/day for adjunct therapy
Take twice daily; can be taken with or without food
Adjust dose in renal impairment
Side Effects ▼
Paresthesia (tingling in hands/feet)
Fatigue, dizziness, somnolence
Weight loss, anorexia
Cognitive effects: difficulty concentrating, memory issues
Kidney stones (rare)
Metabolic acidosis (rare)
Contraindications ▼
Hypersensitivity to topiramate
Metabolic acidosis with previous topiramate therapy
Pregnancy unless benefits outweigh risk
Drug Interaction ▼
Enzyme-inducing antiepileptics (phenytoin, carbamazepine) decrease topiramate levels
Oral contraceptives: may reduce effectiveness at doses ≥200 mg/day
Other carbonic anhydrase inhibitors: increased risk of metabolic acidosis
Pregnancy & Lactation ▼
Pregnancy: May cause cleft lip/palate and other fetal malformations; use only if benefits outweigh risks
Lactation: Excreted in breast milk; avoid or monitor infant
Clinical / Research Summary ▼
Clinical Role: Effective for seizure control and migraine prophylaxis
Advantage: Broad spectrum anticonvulsant, useful in multiple seizure types
Limitation: Cognitive side effects, metabolic risks, teratogenic potential
Monitoring: Renal function, bicarbonate levels, cognitive effects, weight
Patient Counseling Points ▼
Take consistently at same times daily; may sprinkle capsule contents on soft food if needed
Maintain hydration to reduce kidney stone risk
Report tingling, eye problems, cognitive issues, or unusual fatigue
Do not stop abruptly; taper dose under medical guidance
Storage & Handling ▼
Store below 30°C
Protect from moisture and light
Keep out of reach of children
Brand Names (Bangladesh & Global) ▼
Topirva® 50 mg
Medical Disclaimer: For educational purposes only. Not a substitute for professional medical advice.
Reference Hubs:
.png)
